These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8879375)

  • 1. Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE group.
    Favrot MC; Ambros P; Schilling F; Frappaz D; Combaret V; Berthold F; Dominici C; Erttmann R; Esteve J; Jenkner A; Kerbl R; Mann J; Mathieu P; Parker L; Powell J; Philip T
    Ann Oncol; 1996 Aug; 7(6):607-11. PubMed ID: 8879375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biological markers for the prognosis of neuroblastoma: proposal of a method of analysis].
    Combaret V; Delattre O; Bénard J; Favrot MC
    Bull Cancer; 1998 Mar; 85(3):262-6. PubMed ID: 9752317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential application of ELAVL4 real-time quantitative reverse transcription-PCR for detection of disseminated neuroblastoma cells.
    Swerts K; De Moerloose B; Dhooge C; Vandesompele J; Hoyoux C; Beiske K; Benoit Y; Laureys G; Philippé J
    Clin Chem; 2006 Mar; 52(3):438-45. PubMed ID: 16384890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
    Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Yano H; Akiyama H; Ikeda K
    J Pediatr Surg; 1996 Apr; 31(4):555-8. PubMed ID: 8801312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of MMP-2, MMP-9, and TIMP-2 in neuroblastoma: association with tumor progression and clinical outcome.
    Ara T; Fukuzawa M; Kusafuka T; Komoto Y; Oue T; Inoue M; Okada A
    J Pediatr Surg; 1998 Aug; 33(8):1272-8. PubMed ID: 9722003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Limitations in the histopathologic diagnosis and prognosis of neuroblastoma].
    Mihăilă D; Aprodu G; Ionescu C; Miron I; Maxim E; Plămădeală P
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):834-40. PubMed ID: 14756030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both serum and tissue Galectin-1 levels are associated with adverse clinical features in neuroblastoma.
    Chen K; Cai Y; Zhang M; Wu Z; Wu Y
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27229. PubMed ID: 29797641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of molecular and biological tumor markers in neuroblastoma.
    Riley RD; Heney D; Jones DR; Sutton AJ; Lambert PC; Abrams KR; Young B; Wailoo AJ; Burchill SA
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):4-12. PubMed ID: 14734444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
    Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related profile of neuroblastoma: a comparison of tumors detected by mass-screening with those detected clinically.
    Tanaka T; Tanabe M; Sugimoto T; Ida N; Sawada T
    Acta Paediatr Jpn; 1995 Apr; 37(2):154-9. PubMed ID: 7793247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Relationship Between Apoptotic Activity and Prognostic Factors in Neuroblastomas.
    Ekmekci S; Olgun N; Özer E
    Turk Patoloji Derg; 2016; 32(2):99-104. PubMed ID: 27136108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.
    Owens C; Irwin M
    Crit Rev Clin Lab Sci; 2012; 49(3):85-115. PubMed ID: 22646747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysialylated neural cell adhesion molecule in childhood ganglioneuroma and neuroblastoma of different histological grade and clinical stage.
    Glüer S; Zense M; Radtke E; von Schweinitz D
    Langenbecks Arch Surg; 1998 Oct; 383(5):340-4. PubMed ID: 9860228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
    Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
    Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the proliferative activity in neuroblastoma.
    Rudolph P; Lappe T; Hero B; Berthold F; Parwaresch R; Harms D; Schmidt D
    Am J Pathol; 1997 Jan; 150(1):133-45. PubMed ID: 9006330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.
    Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Fukuba I; Matsuura Y; Yokoyama T
    Med Pediatr Oncol; 2001 Jan; 36(1):67-74. PubMed ID: 11464909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between morphologic and other prognostic markers of neuroblastoma. A study of histologic grade, DNA index, N-myc gene copy number, and lactic dehydrogenase in patients in the Pediatric Oncology Group.
    Joshi VV; Cantor AB; Brodeur GM; Look AT; Shuster JJ; Altshuler G; Larkin EW; Holbrook CT; Silverman JF; Norris HT
    Cancer; 1993 May; 71(10):3173-81. PubMed ID: 8490848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroblastoma in the very young child: biological considerations.
    Kemshead JT; Patel K; Phimister B
    Br J Cancer Suppl; 1992 Aug; 18():S102-5. PubMed ID: 1503919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: a molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues.
    Poremba C; Scheel C; Hero B; Christiansen H; Schaefer KL; Nakayama Ji; Berthold F; Juergens H; Boecker W; Dockhorn-Dworniczak B
    J Clin Oncol; 2000 Jul; 18(13):2582-92. PubMed ID: 10893290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.